1-22 of 22
Keywords: Alzheimer’s disease
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Articles
Biosci Rep (2021) 41 (4): BSR-20180051_EOC.
Published: 09 April 2021
... © 2021 The Author(s). 2021 This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) . Aβ Alzheimer's disease BACE1 miR-15b NF-κB The Editorial Office has...
Articles
Articles
Articles
Articles
Biosci Rep (2020) 40 (3): BSR20194295.
Published: 27 March 2020
...Wanru Xu; Kai Li; Qian Fan; Biyun Zong; Ling Han Background: Alzheimer’s disease (AD), which has no effective drugs to delay or prevent its progression, is a multifactorial complex neurodegenerative disease. Long non-coding RNA SOX21 antisense RNA1 (SOX21-AS1) is associated with the development...
Articles
Biosci Rep (2019) 39 (12): BSR20181404.
Published: 13 December 2019
...Mahdi Rahaie; Saman Khayat Noroozi Multiplex assays for detection of biomarkers, provide advantageous analyses of different factors related to diagnoses of diseases. The Alzheimer’s disease (AD) is one of the most common disease in old people in societies which is increasing, significantly. A group...
Articles
Biosci Rep (2019) 39 (9): BSR20190488.
Published: 20 September 2019
.... In addition, inhibitors of hyperphosphorylated τ, glutamate receptor modulators, nerve growth factors and estrogen replacement therapies, were also common; however, their clinical efficiencies were still below satisfaction [ 4 ]. Alzheimer’s disease amyloid-β free radical Mangiferin SAMP8...
Articles
Articles
Articles
Articles
Biosci Rep (2018) 38 (6): BSR20180051.
Published: 14 November 2018
...Juan Li; Haitao Wang Alzheimer’s disease (AD) is the multifactorial neurodegenerative disorder causing progressive memory loss and cognitive impairment. The aberrant accumulation of amyloid-β (Aβ) and neuroinflammation are two major events in AD. BACE1 is required for the cleavage of amyloid...
Articles
Biosci Rep (2018) 38 (4): BSR20171284.
Published: 13 July 2018
... developed an animal model presenting both Alzheimer’s disease (AD) and type 2 diabetes (T2D), by crossing APP/PS1 mice (AD model) with streptozotocin (STZ)-treated mice (a T2D model). Neuronal apoptosis was detected by TUNEL staining and the expression levels of apoptosis-related proteins were examined...
Articles
Articles
Biosci Rep (2016) 36 (2): e00319.
Published: 15 April 2016
... work has shown that the intracellular domain of the amyloid precursor protein (APP), a molecule central to the aetiology of Alzheimer's disease binds to VAC14 and enhances PIKfyve function. In the present study, we utilize this recent advance to create an easy-to-use tool for increasing PIKfyve...
Articles
Biosci Rep (2016) 36 (2): e00308.
Published: 16 March 2016
...Hongyun Li; Tim Karl; Brett Garner ATP-binding cassette transporter A7 (ABCA7) is highly expressed in the brain. Recent genome-wide association studies (GWAS) have identified ABCA7 single nucleotide polymorphisms (SNPs) that increase Alzheimer's disease (AD) risk, however, the mechanisms by which...
Articles
Articles
Biosci Rep (2014) 34 (6): e00155.
Published: 24 November 2014
...Genadiy Fonar; Abraham O. Samson Alzheimer's disease is the most common neurodegenerative disorder in the world. Its most significant symptoms are memory loss and decrease in cognition. Alzheimer's disease is characterized by aggregation of two proteins in the brain namely Aβ (amyloid β) and tau...
Articles
Biosci Rep (2007) 27 (1-3): 87–104.
Published: 13 June 2007
... in mitochondria in various tissues of patients with neurodegenerative disorders, the question “is mitochondrial dysfunction a necessary step in neurodegeneration?” is still unanswered. In this review, we highlight some of the major neurodegenerative disorders (Alzheimer's disease, Parkinson's disease, Amyotrophic...
Articles
Biosci Rep (2006) 26 (5): 341–367.
Published: 09 November 2006
... of the major neurodegenerative disorders (Alzheimer's disease, Parkinson's disease, Amyotrophic lateral sclerosis, Huntington's disease, and prion diseases.) and discuss possible links of gene–environment interplay including, where implicated, mitochondrial genes. © 2006 Springer Science+Business Media, LLC...
Articles
Biosci Rep (2005) 25 (5-6): 309–327.
Published: 12 October 2005
... signaling in neurodegenerative and hyperproliferative diseases might impinge on the same molecular mechanisms, different pharmacological outcomes are required. Here we review recent developments on the understanding of the role of Wnt signaling in Alzheimer's disease and CNS tumors, and identify possible...
Articles
Biosci Rep (1986) 6 (5): 459–465.
Published: 01 May 1986
... Publishing Corporation 1986 SAF amyloid fibril protein Alzheimer's disease systemic amyloidosis Bioscience Reports, Vol. 6, No. 5, 1986 Scrapie-Associated Fibrils (SAF) Purification Method Yields Amyloid Proteins from Systemic and Cerebral Amyloidosis Tetsuyuki Kitamoto, l'3 Kohtaro Hikita,1...